Results 151 to 160 of about 17,783 (291)

The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelers [PDF]

, 1992
A multicenter prospective trial was performed to investigate the efficacy and the tolerability of halofantrine in nonimmune patients with malaria imported from areas with drug-resistant falciparum parasites (mainly Africa).
Bock, H. L., Clemens, R., Fleischer, K., Kohler, B., Kretschmer, H., Löscher, Thomas, Pohle, H. D., Schlunk, T., Weinke, T.   +8 more
core   +1 more source

Influence of Amodiaquine Treatment on Microsomal Lipid Peroxidation and Antioxidant Defense Systems of Rats [PDF]

, 2000
E. Olatunde Farombi
openalex   +1 more source

Interactions of the antimalarial amodiaquine with lipid model membranes

Chemistry and Physics of Lipids, 2015
A detailed molecular description of the mechanism of action of the antimalarial drug amodiaquine (AQ) is still an open issue. To gain further insights on that, we studied the interactions of AQ with lipid model membranes composed of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylserine (DPPS) by spin labeling electron spin resonance ...
Luis G.M. Basso, Rafael P. Barroso, Antonio J. Costa-Filho   +2 more
openaire   +3 more sources

Knowledge, attitudes and practices of malaria control among communities from the health district of Forécariah in the Republic of Guinea, West Africa. [PDF]

, 2014
BACKGROUND & OBJECTIVES: Malaria is the leading cause of death in children under 5-yr of age in the Republic of Guinea. This study aimed at investigating the knowledge, attitudes and practices of malaria control in urban and rural communities in Guinea ...
Banek, Kristin, Camara, Seydouba, Loua, Marcel Kovana, Ruberto, Irene   +3 more
core   +1 more source

Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment

Pharmacogenomics and Personalized Medicine, 2020
Lidia Habtemikael,1 Mulugeta Russom,2 Iyassu Bahta,2 Selam Mihreteab,3 Araia Berhane,4 Andreas Mårtensson,1 Jose Pedro Gil1,5,6 1Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala ...
Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, Gil JP   +6 more
doaj  

Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. [PDF]

, 2001
B Ngouesse, Léonardo K. Basco, Pascal Ringwald, A Keundjian, Kathleen Ngu Blackett   +4 more
openalex   +1 more source

From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns

Scientific Reports, 2017
Drug repositioning identifies new indications for known drugs. Here we report repositioning of the malaria drug amodiaquine as a potential anti-cancer agent.
Sebastian Salentin, Melissa F. Adasme, J. Heinrich, V. J. Haupt, Simone Daminelli, Yixin Zhang, M. Schroeder   +6 more
semanticscholar   +1 more source

Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate [PDF]

, 2001
Catherine Orrell, Walter R. J. Taylor, P. Offiaro   +2 more
openalex   +1 more source

Combination of Drug Level Measurement and Parasite Genotyping Data for Improved Assessment of Amodiaquine and Sulfadoxine-Pyrimethamine Efficacies in Treating Plasmodium falciparum Malaria in Gabonese Children [PDF]

, 2002
Agnès Aubouy, Mohamed Bakary, A Keundjian, Bernard Mbomat, Jean Ruffin Makita, Florence Migot‐Nabias, Michel Cot, Jacques Le Bras, Philippe Deloron   +8 more
openalex   +1 more source

Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria

Bulletin of the World Health Organization
OBJECTIVE: To test a novel methodology to define age-based dosing regimens for the treatment of malaria with a new, user-friendly, blister-packaged fixed-dose combination of artesunate and amodiaquine.
Walter RJ Taylor, Dianne J Terlouw, Piero L Olliaro, Nicholas J White, Philippe Brasseur, Feiko O ter Kuile   +5 more
doaj   +1 more source